[{"Assets_0_FY_USD":817591000.0,"CommonStockSharesOutstanding_0_FY_shares":88793903.0,"EarningsPerShareBasic_1_FY_USD":0.08,"EarningsPerShareBasic_4_FY_USD":-1.62,"EarningsPerShareDiluted_1_FY_USD":0.07,"EarningsPerShareDiluted_4_FY_USD":-1.62,"NetIncomeLoss_1_FY_USD":6894000.0,"NetIncomeLoss_4_FY_USD":-142542000.0,"StockholdersEquity_0_FY_USD":372138000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_FY_shares":92659000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_4_FY_shares":88089000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_FY_shares":88665000.0,"WeightedAverageNumberOfSharesOutstandingBasic_4_FY_shares":88089000.0,"Ticker":"NBIX","CIK":"914475","name":"NEUROCRINE BIOSCIENCES INC","OfficialName":"Neurocrine Biosciences Inc. Common Stock","form":"10-K","period":"20171231","fy":"2017.0","fp":"FY","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"9338885763.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20180213"}]